SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine.
Wobst HJ, Viader A, Muncipinto G, Hollibaugh R, van Kalken D, Burkhart CT, Cantin SM, Bates RM, Regimbald-Dumas Y, Gross L, Antalek MT, Zweig JE, Wu F, Rettenmaier TJ, Labenski MT, Pullen N, Blanchette HS, Henderson JL, Weng HH, Vaughn TA, Brown DG, Throup JP, Barrish JC.
Wobst HJ, et al. Among authors: brown dg.
JCI Insight. 2024 Nov 8;9(21):e182876. doi: 10.1172/jci.insight.182876.
JCI Insight. 2024.
PMID: 39513367
Clinical Trial.